BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32948640)

  • 21. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
    Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
    PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2012 Jan; 460(1):77-87. PubMed ID: 22120431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types.
    Sugiyama T; Nishida T; Kataoka A; Okura N; Iwanaga S; Yakushiji M
    Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):47-50. PubMed ID: 9076421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometriosis-associated epithelial ovarian cancer: Primary synchronous different cellular type on each ovary.
    Sao CH; Lai WA; Lin SC; Chang CM; Chen YJ; Wang PH
    Taiwan J Obstet Gynecol; 2020 May; 59(3):460-463. PubMed ID: 32416900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma.
    Pozzati F; Moro F; Pasciuto T; Gallo C; Ciccarone F; Franchi D; Mancari R; Giunchi S; Timmerman D; Landolfo C; Epstein E; Chiappa V; Fischerova D; Fruscio R; Zannoni GF; Valentin L; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):792-800. PubMed ID: 29978567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.
    Takahashi K; Takenaka M; Kawabata A; Yanaihara N; Okamoto A
    Int J Clin Oncol; 2020 Mar; 25(3):425-431. PubMed ID: 31989349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
    Tan TZ; Ye J; Yee CV; Lim D; Ngoi NYL; Tan DSP; Huang RY
    EBioMedicine; 2019 Dec; 50():203-210. PubMed ID: 31761620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear-cell carcinoma of the ovary.
    Fujiwara K; Shintani D; Nishikawa T
    Ann Oncol; 2016 Apr; 27 Suppl 1():i50-i52. PubMed ID: 27141072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions.
    Davidson B
    Cancer Cytopathol; 2014 Feb; 122(2):153-8. PubMed ID: 24115587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.
    Kato N
    Pathol Int; 2020 Sep; 70(9):591-601. PubMed ID: 32476214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).
    Lopes-Coelho F; Gouveia-Fernandes S; Gonçalves LG; Nunes C; Faustino I; Silva F; Félix A; Pereira SA; Serpa J
    Tumour Biol; 2016 Apr; 37(4):4813-29. PubMed ID: 26520442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
    Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
    Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
    Prat J; D'Angelo E; Espinosa I
    Hum Pathol; 2018 Oct; 80():11-27. PubMed ID: 29944973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.
    Abe A; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
    Hum Pathol; 2013 Feb; 44(2):199-207. PubMed ID: 22955107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.
    Kita T; Kikuchi Y; Kudoh K; Takano M; Goto T; Hirata J; Tode T; Nagata I
    Oncol Rep; 2000; 7(2):327-31. PubMed ID: 10671681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
    Wiegand KC; Hennessy BT; Leung S; Wang Y; Ju Z; McGahren M; Kalloger SE; Finlayson S; Stemke-Hale K; Lu Y; Zhang F; Anglesio MS; Gilks B; Mills GB; Huntsman DG; Carey MS
    BMC Cancer; 2014 Feb; 14():120. PubMed ID: 24559118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.
    Goff BA; Sainz de la Cuesta R; Muntz HG; Fleischhacker D; Ek M; Rice LW; Nikrui N; Tamimi HK; Cain JM; Greer BE; Fuller AF
    Gynecol Oncol; 1996 Mar; 60(3):412-7. PubMed ID: 8774649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
    Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG
    Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
    Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.